Key Insights

Highlights

Treatment Research

2 treatments under study, led by Custodiol Htk Solution

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03627013Phase 3Recruiting

Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)

Showing all 1 trials

Research Network

Common Treatments

  • Custodiol Htk Solution1
  • Custodioln Solution1

Active Sponsors

  • Dr. F. Köhler Chemie GmbH1
  • Dr. Franz Koehler Chemie GmbH1

Related Conditions

  • Kidney Failure1
  • Liver Failure Chronic1
  • Patients Who Will Undergo Kidney Liver Or Kidneypancreatictransplantation1

Activity Timeline